These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3195663)

  • 21. Deposits in the superficial corneal stroma after combined topical corticosteroid and beta-blocking medication.
    Huige WM; Beekhuis WH; Rijneveld WJ; Schrage N; Remeijer L
    Eur J Ophthalmol; 1991; 1(4):198-9. PubMed ID: 1821214
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of treatment for dry eye with 2-hydroxyestradiol using a dry eye rat model.
    Higuchi A; Oonishi E; Kawakita T; Tsubota K
    Mol Vis; 2016; 22():446-53. PubMed ID: 27186071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid and the ocular surface.
    Samarawickrama C; Chew S; Watson S
    Surv Ophthalmol; 2015; 60(3):183-95. PubMed ID: 25890622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing Corneal Calcification Associated With Xylazine for Longitudinal Optical Coherence Tomography in Young Rodents.
    Zhou TE; Sayah DN; Noueihed B; Mazzaferri J; Costantino S; Brunette I; Chemtob S
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):461-469. PubMed ID: 28122088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of conjunctival epithelial evaluation in the diagnostic differentiation of dry eye from drug-induced epithelial keratopathy.
    Yokoi N; Kinoshita S
    Adv Exp Med Biol; 1998; 438():827-30. PubMed ID: 9634973
    [No Abstract]   [Full Text] [Related]  

  • 26. [Phosphate in ophthalmologic solutions].
    Bernauer W; Thiel MA; Rentsch KM
    Ophthalmologe; 2006 May; 103(5):416-7. PubMed ID: 16622640
    [No Abstract]   [Full Text] [Related]  

  • 27. Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects.
    Mondy P; Brama T; Fisher J; Gemelli CN; Chee K; Keegan A; Waller D
    Transfus Apher Sci; 2015 Dec; 53(3):404-11. PubMed ID: 26626963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing the composition of buffered eye-drops prevents undesired side effects.
    Schrage NF; Frentz M; Reim M
    Br J Ophthalmol; 2010 Nov; 94(11):1519-22. PubMed ID: 20650912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a role for neurotrophin treatment of the ocular surface following laser in situ keratomileusis (LASIK)?
    Pepose JS; Johnson EM
    Am J Ophthalmol; 2005 Jun; 139(6):1090-4. PubMed ID: 15953442
    [No Abstract]   [Full Text] [Related]  

  • 31. Thymosin beta 4 and the eye: the journey from bench to bedside.
    Sosne G
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):99-104. PubMed ID: 30063853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dry eye].
    Cursiefen C
    Ophthalmologe; 2013 Jun; 110(6):498-9. PubMed ID: 23783991
    [No Abstract]   [Full Text] [Related]  

  • 33. Deep corneal calcification associated with preservative-free eyedrops and persistent epithelial defects.
    Lake D; Tarn A; Ayliffe W
    Cornea; 2008 Apr; 27(3):292-6. PubMed ID: 18362655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calcareous degeneration of the canine cornea.
    Sansom J; Blunden T
    Vet Ophthalmol; 2010 Jul; 13(4):238-43. PubMed ID: 20618802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases.
    Sosne G; Rimmer D; Kleinman HK; Ousler G
    Vitam Horm; 2016; 102():277-306. PubMed ID: 27450739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of CIN with retinoic acid and topical interferon alfa-2b.
    Huerva V
    Ophthalmology; 2013 Aug; 120(8):e55. PubMed ID: 23916085
    [No Abstract]   [Full Text] [Related]  

  • 37. Corneal surface regularity and the effect of artificial tears in aqueous tear deficiency.
    Liu Z; Pflugfelder SC
    Ophthalmology; 1999 May; 106(5):939-43. PubMed ID: 10328393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Viscous Agents on Corneal Density in Dry Eye Disease.
    Wegener AR; Meyer LM; Schönfeld CL
    J Ocul Pharmacol Ther; 2015 Oct; 31(8):504-8. PubMed ID: 26102300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of artificial tears on corneal surface regularity in dry eye].
    Liu Z; Xie Y; Zhang M; Pflugfelder SC
    Zhonghua Yan Ke Za Zhi; 2000 Mar; 36(2):131-4. PubMed ID: 11853602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular Surface Disease in the Glaucoma Patient.
    Banitt M; Jung H
    Int Ophthalmol Clin; 2018; 58(3):23-33. PubMed ID: 29870408
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.